McKinsey, JPMorgan Chase drop Purdue Pharma amid opioid scrutiny
Companies are distancing themselves from the Oxycontin maker and its founding family amid thousands of lawsuits
Companies are distancing themselves from the Oxycontin maker and its founding family amid thousands of lawsuits